РЕЗУЛЬТАТЫ ПРИМЕНЕНИЯ СХЕМЫ АНТИРЕТРОВИРУСНОЙ ТЕРАПИИ «ТИМАЗИД + ХИВИД + ВИРАСЕПТ» У ВЗРОСЛЫХ И ДЕТЕЙ

In the task are introduced the results of the first scheme of antiretroviral therapy «Timazid+ Hivid + Viracept» implementation by adults and children. Also is showed the inconvenience of the scheme using by bigger quantity of patients, its minimum toxicity, virological and immunological efficiency after 12 months